Major bleeding risks of different low-molecular-weight heparin agents: a cohort study in 12 934 patients treated for acute venous thrombosis

N. van Rein, J. S. Biedermann, F. J. M. van der Meer, S. C. Cannegieter, N. Wiersma, H. W. Vermaas, P. H. Reitsma, M. J. H. A. Kruip, W. M. Lijfering
  • Journal of Thrombosis and Haemostasis, May 2017, Wiley
  • DOI: 10.1111/jth.13715

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

The following have contributed to this page: Suzanne Cannegieter, Professor PIETER H. REITSMA, and Willem Lijfering